Images for illustrative purposes only

How it works?

Online Consultation

We ask you to complete a quick and easy consultation and get you started.

Choose condition

We have a selection of treatments available for various conditions.

Express Delivery

You will have complete visibility and control of your delivery.
Notice!

Before ordering this treatment, you may have to complete an online consultation

Overview

Rybelsus (semaglutide) is the first GLP-1 treatment available in tablet form. Supplied by SwiftMedi following a secure online consultation with a UK-registered prescriber, your treatment will be dispensed from our UK-regulated pharmacy and delivered quickly and discreetly to your door.


What is Rybelsus


Rybelsus contains semaglutide — the same active ingredient found in Wegovy and Ozempic — but in a once-daily tablet. It is licensed in the UK for type 2 diabetes, where it helps regulate blood sugar, reduce appetite, and support weight management.

Unlike injections, Rybelsus is swallowed once daily with water, making it a convenient and needle-free option for patients who prefer tablets. It works by mimicking the natural hormone GLP-1, slowing digestion, reducing hunger, and helping you feel fuller for longer.

Many patients taking Rybelsus notice not only better blood sugar control, but also a reduction in appetite and gradual weight loss — reflecting the same mechanisms that make injectable semaglutide highly effective for weight management.

Directions

Administration: Take one tablet daily with a small amount of water, on an empty stomach, at least 30 minutes before eating or drinking.


Dosing schedule: Treatment usually begins with a lower dose (3mg) and is increased gradually as advised by your prescriber.


Duration: Rybelsus is intended for long-term use in type 2 diabetes management.

Side Effects

As with other semaglutide treatments, most side effects are mild and temporary, improving as your body adjusts.

Common (may affect up to 1 in 10 people):

  • Nausea or feeling sick
  • Diarrhoea or constipation
  • Reduced appetite
  • Indigestion or bloating


Less common (may affect up to 1 in 100 people):

  • Vomiting
  • Abdominal pain
  • Tiredness
  • Stomach discomfort


Rare but serious (seek urgent medical advice):

  • Severe abdominal pain (possible pancreatitis)
  • Signs of allergic reaction (rash, swelling, difficulty breathing)


Disclaimer: This is not a complete list of side effects. Always read the patient information leaflet that comes with your medicine for full details. If you notice anything unusual or concerning, stop treatment and seek medical advice promptly. In an emergency, call 999 or go to A&E.

Warnings

Rybelsus may not be suitable for everyone. You should not use it if you:

  • Have a personal or family history of medullary thyroid cancer
  • Have multiple endocrine neoplasia syndrome type 2 (MEN2)
  • Are pregnant or breastfeeding
  • Have severe gastrointestinal disease or pancreatitis


Always complete your consultation truthfully so your prescriber can confirm if Rybelsus is safe for you.

FAQ's

What is Rybelsus used for?
Rybelsus is licensed for type 2 diabetes to help regulate blood sugar. Many patients also notice reduced appetite and weight loss as part of treatment.

Is Rybelsus the same as Wegovy or Ozempic?
Yes, they all contain semaglutide. The main difference is that Rybelsus is taken as a daily tablet, while Wegovy and Ozempic are weekly injections.

How do I take Rybelsus correctly?
Take your tablet first thing in the morning with a sip of water, at least 30 minutes before food or drink. This ensures proper absorption.

Can Rybelsus help with weight loss?
Although licensed for diabetes, many patients find Rybelsus reduces appetite and leads to gradual weight loss, due to the same mechanisms that make semaglutide injections effective.

Who might prefer Rybelsus?
Rybelsus is ideal for patients who prefer a needle-free alternative to injections while still benefiting from semaglutide’s proven effects.